Hyperway (Drug Discovery) Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 100

Employees

  • Latest Deal Type
  • Series B1

  • Latest Deal Amount
  • $14.9M

  • Investors
  • 19

Hyperway (Drug Discovery) General Information

Description

Manufacturer of innovative small-molecule therapeutics intended to address oncology, pain management and central nervous system disorders. The company focuses on discovering and developing first-in-class (FIC) and best-in-class (BIC) targeted drugs, leveraging proprietary drug design, brain-penetration technologies, and advanced medicinal chemistry capabilities to deliver novel treatments for unmet medical needs worldwide.

Contact Information

Website
www.hyperwaypharma.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 8th Floor, Building B4, Tianfu Life Science Park
  • Number 88 Keyuan South Road, High-tech Zone
  • Chengdu, Sichuan 610041
  • China
+86 028
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
Manufacturing, Life Sciences, Oncology
Corporate Office
  • 8th Floor, Building B4, Tianfu Life Science Park
  • Number 88 Keyuan South Road, High-tech Zone
  • Chengdu, Sichuan 610041
  • China
+86 028

Hyperway (Drug Discovery) Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hyperway (Drug Discovery) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC (Series B1) 30-Sep-2026 $14.9M Completed Generating Revenue
10. Secondary Transaction - Private 30-Sep-2026 Completed Generating Revenue
9. Later Stage VC (Series B) 22-Oct-2025 Completed Generating Revenue
8. Secondary Transaction - Private 29-Aug-2025 Completed Generating Revenue
7. Early Stage VC (Series A1) 08-Jan-2024 Completed Generating Revenue
6. Early Stage VC 20-Nov-2023 Completed Generating Revenue
5. Early Stage VC 08-Aug-2023 Completed Generating Revenue
4. Early Stage VC (Series A) 14-Apr-2021 Completed Generating Revenue
3. Early Stage VC 08-May-2020 $77.9K $204K Completed Generating Revenue
2. Early Stage VC 25-Mar-2020 $126K $126K Completed Generating Revenue
To view Hyperway (Drug Discovery)’s complete valuation and funding history, request access »

Hyperway (Drug Discovery) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hyperway (Drug Discovery) Investors (19)

Investor Name Investor Type Holding Investor Since Participating Rounds
Chengdu Technology Transfer Venture Corporate Venture Capital Minority
Chongqing Yufu Assets Management Group Asset Manager Minority
Hengdian Capital Venture Investment (Zhejiang) Growth/Expansion Minority
In Capital Venture Capital Minority
Daoyuan Capital Venture Capital Minority
You’re viewing 5 of 19 investors. Get the full list »

Ready to get started?

Request a free trial

Hyperway (Drug Discovery) FAQs

  • When was Hyperway (Drug Discovery) founded?

    Hyperway (Drug Discovery) was founded in 2019.

  • Where is Hyperway (Drug Discovery) headquartered?

    Hyperway (Drug Discovery) is headquartered in Chengdu, China.

  • What is the size of Hyperway (Drug Discovery)?

    Hyperway (Drug Discovery) has 100 total employees.

  • What industry is Hyperway (Drug Discovery) in?

    Hyperway (Drug Discovery)’s primary industry is Drug Discovery.

  • Is Hyperway (Drug Discovery) a private or public company?

    Hyperway (Drug Discovery) is a Private company.

  • What is Hyperway (Drug Discovery)’s current revenue?

    The current revenue for Hyperway (Drug Discovery) is .

  • How much funding has Hyperway (Drug Discovery) raised over time?

    Hyperway (Drug Discovery) has raised $57.2M.

  • Who are Hyperway (Drug Discovery)’s investors?

    Chengdu Technology Transfer Venture, Chongqing Yufu Assets Management Group, Hengdian Capital Venture Investment (Zhejiang), In Capital, and Daoyuan Capital are 5 of 19 investors who have invested in Hyperway (Drug Discovery).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process